CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...
Phase 3
Southfield, Michigan, United States and 217 other locations
study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID...
Phase 3
Detroit, Michigan, United States and 19 other locations
This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI--...
Phase 2
Sterling Heights, Michigan, United States and 54 other locations
be tolerated for treatment of pregnant women with mild or moderate COVID-19 compared to non-pregnant women with mild or moderate CO-...
Phase 1
Farmington Hills, Michigan, United States of America and 32 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
Detroit, Michigan, United States and 214 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Ann Arbor, Michigan, United States and 66 other locations
The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...
Phase 3
Southfield, Michigan, United States and 162 other locations
study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...
Phase 2, Phase 3
Detroit, Michigan, United States and 109 other locations
the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...
Phase 4
Detroit, Michigan, United States and 39 other locations
This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...
Phase 2, Phase 3
Grosse Pointe Woods, Michigan, United States and 90 other locations
Clinical trials
Research sites
Resources
Legal